Literature DB >> 16770534

Clinical patterns of metastasis.

Stanley P L Leong1, Blake Cady, David M Jablons, Julio Garcia-Aguilar, Douglas Reintgen, J Jakub, S Pendas, L Duhaime, R Cassell, M Gardner, R Giuliano, V Archie, D Calvin, L Mensha, S Shivers, C Cox, J A Werner, Y Kitagawa, M Kitajima.   

Abstract

In human solid cancer, lymph node status is the most important indicator for clinical outcome. Recent developments in the sentinel lymph node concept and technology have resulted in a more precise way of examining micrometastasis in the sentinel lymph node and the role of lymphovascular system in the facilitation of cancer metastasis. Different patterns of metastasis are described with respect to different types of solid cancer. Expect perhaps for papillary carcinoma and sarcoma, the overwhelming evidence is that solid cancer progresses in an orderly progression from the primary site to the regional lymph node or the sentinel lymph node in the majority of cases with subsequent dissemination to the systemic sites. The basic mechanisms of cancer metastasis through the lymphovascular system form the basis of rational therapy against cancer. Beyond the clinical patterns of metastasis, it is imperative to understand the biology of metastasis and to characterize patterns of metastasis perhaps due to heterogeneous clones based on their molecular signatures.

Entities:  

Mesh:

Year:  2006        PMID: 16770534     DOI: 10.1007/s10555-006-8502-8

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  54 in total

1.  Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease.

Authors:  Tovë M Goldson; Yimei Han; Kristen B Knight; Heidi L Weiss; Vicente A Resto
Journal:  J Exp Ther Oncol       Date:  2010

2.  Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells.

Authors:  Jaehyup Kim; Leah E Escalante; Bridget A Dollar; Summer E Hanson; Peiman Hematti
Journal:  Cancer Invest       Date:  2013-09-10       Impact factor: 2.176

3.  Glycomic profiling of invasive and non-invasive breast cancer cells.

Authors:  John A Goetz; Yehia Mechref; Pilsoo Kang; Meei-Huey Jeng; Milos V Novotny
Journal:  Glycoconj J       Date:  2008-08-28       Impact factor: 2.916

4.  Management of regional lymph node basins in melanoma.

Authors:  Timothy P Love; Keith A Delman
Journal:  Ochsner J       Date:  2010

5.  Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.

Authors:  Valentine Heidelberger; François Goldwasser; Nora Kramkimel; Anne Jouinot; Nathalie Franck; Jennifer Arrondeau; Sarah Guégan; Audrey Mansuet-Lupo; Jérôme Alexandre; Diane Damotte; Marie-Françoise Avril; Nicolas Dupin; Sélim Aractingi
Journal:  Invest New Drugs       Date:  2017-05-31       Impact factor: 3.850

6.  Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.

Authors:  Eben L Rosenthal; Lindsay S Moore; Kiranya Tipirneni; Esther de Boer; Todd M Stevens; Yolanda E Hartman; William R Carroll; Kurt R Zinn; Jason M Warram
Journal:  Clin Cancer Res       Date:  2017-04-26       Impact factor: 12.531

7.  Stage IV colorectal cancer primary site and patterns of distant metastasis.

Authors:  Jamaica R Robinson; Polly A Newcomb; Sheetal Hardikar; Stacey A Cohen; Amanda I Phipps
Journal:  Cancer Epidemiol       Date:  2017-04-21       Impact factor: 2.984

8.  Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.

Authors:  Elin Hadler-Olsen; Hilde Ljones Wetting; Oddveig Rikardsen; Sonja E Steigen; Premasany Kanapathippillai; Reidar Grénman; Jan-Olof Winberg; Gunbjørg Svineng; Lars Uhlin-Hansen
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

9.  Targeting lymphatic vessel functions through tyrosine kinases.

Authors:  Steven P Williams; Tara Karnezis; Marc G Achen; Steven A Stacker
Journal:  J Angiogenes Res       Date:  2010-08-11

10.  PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.

Authors:  Barbara Garmy-Susini; Christie J Avraamides; Jay S Desgrosellier; Michael C Schmid; Philippe Foubert; Lesley G Ellies; Andrew M Lowy; Sarah L Blair; Scott R Vandenberg; Brian Datnow; Huan-You Wang; David A Cheresh; Judith Varner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.